Medicine
Showing 421-440 of 1,153 Results
-
William Hui, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Hui is a family medicine physician. He practices in the Stanford Family Medicine clinic in Palo Alto and is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population Health. He serves as the point-of-care ultrasound (POCUS) and Minor Procedure Service Director in the Division of Primary Care and Population Health.
Dr. Hui completed fellowship training in point-of-care ultrasound at the University of Pennsylvania. He trained as a resident in family medicine at Stanford Health Care - O'Connor Hospital after earning his medical degree at Drexel University College of Medicine.
He is interested in the utilization of point of care ultrasound in outpatient primary care.
Dr. Hui is a member of the American Academy of Family Physicians, American Institute of Ultrasound in Medicine, and Society of Teachers of Family Medicine.
Dr. Hui enjoys long-distance running and bouldering in his free time. He is also a coffee enthusiast.
He speaks English fluently and Cantonese with limited working proficiency. -
Sharon Wei Hung
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioSharon Hung MD, FACP is a board-certified Internal Medicine physician practicing at the Stanford Internal Medicine Clinic in Santa Clara. She earned her MD from the Northwestern University Feinberg School of Medicine and completed her internal medicine residency at Cedars-Sinai Medical Center. Prior to joining Stanford, she served on the faculty at the University of Arizona College of Medicine.
Dr. Hung is the Director of Women’s Health for the Department of Primary Care and Population Health. In this role, she served as course director for Stanford CME’s Women’s Health Conference and continues to co-direct the annual Stanford CME Menopause and Healthy Aging Conference. She also hosts the Stanford CME/YouTube Women’s Health Vodcast, where she interviews leading experts and explores timely, clinically relevant topics in women’s health.
Her scholarly interests include breast cancer screening, steatotic liver disease, osteoporosis, and weight gain during the perimenopausal period. Clinically, she is dedicated to preventive medicine and the management of chronic conditions such as pre-diabetes, obesity and metabolic syndrome, as well as guiding women through the perimenopausal transition. Dr. Hung also leads bi-monthly group patient visits focused on the prevention and treatment of osteoporosis. She is passionate about inspiring trainees and works with both Stanford Internal Medicine residents and Physician Assistant students.
She is conversational in both Spanish and Mandarin. -
Jennifer L. Hunter, PA-C
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioJennifer Hunter, PA-C is the Lead Advanced Practice Provider (APP) for the Emergency Department & Clinical Decision Unit (CDU) with experience in Adult Congenital Heart Disease (ACHD) and over 10 years of experience in Emergency Medicine. She is also a Clinical Assistant Professor and Educator-4-Care (E4C) at the Stanford School of Medicine & Masters of Science in PA Studies Program.
-
Yusra Hussain, M.D.
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsCollaborator in the HALF study
Collaborator in the PROMISE study
Primary Investigator, Bidet Pilot Study- 650-644-9230 -
Tridu Huynh
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsMulti-Omics in Clonal Hematopoiesis of Indeterminate Potential
Undiagnosed Disease Network -
Joo Ha Hwang, MD, PhD
Fortinet Founders School of Medicine Professor and Professor, by courtesy, of Surgery
Current Research and Scholarly InterestsSpecialize in early detection of gastrointestinal malignancies including esophageal, gastric, pancreatic, bile duct & colon cancers. I have both a clinical & research interest in improving the early detection of gastric cancer in particular. I am the PI of the Gastric Precancerous conditions Study, a prospective study of patients with gastric intestinal metaplasia & other precancerous conditions which combines comprehensive clinical & endoscopic data with a large bio-specimen repository.
-
David Iberri
Clinical Associate Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
John P.A. Ioannidis
Professor of Medicine (Stanford Prevention Research Center), of Epidemiology and Population Health and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsMeta-research
Evidence-based medicine
Clinical and molecular epidemiology
Human genome epidemiology
Research design
Reporting of research
Empirical evaluation of bias in research
Randomized trials
Statistical methods and modeling
Meta-analysis and large-scale evidence
Prognosis, predictive, personalized, precision medicine and health
Sociology of science -
Eric Ip
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy research interests include the use and abuse of anabolic steroids and other performance enhancing/cognitive enhancing drugs.
-
Haruka Itakura, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Haruka Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine, a data scientist, and a practicing breast medical oncologist at the Stanford Women’s Cancer Center. She is board-certified in Oncology, Clinical Informatics, Hematology, and Internal Medicine. Her research mission is to drive medical advances at the intersection of cancer and data science, applying state-of-the-art machine learning/artificial intelligence (AI) techniques to extract clinically actionable knowledge from heterogeneous multi-scale cancer data to improve patient outcomes. Her ongoing research to develop robust methodologies and apply cutting-edge techniques to analyze complex cancer big data was catapulted by an NIH K01 Career Development Award in Biomedical Big Data Science after obtaining a PhD in Biomedical Informatics at Stanford University. Her cancer research focuses on extracting radiomic (pixel-level quantitative imaging) features of tumors from medical imaging studies and applying machine learning frameworks, including radiogenomic approaches, for the integrative analysis of heterogeneous, multiomic (e.g., radiomic, genomic, transcriptomic) data to accelerate discoveries in cancer diagnostics and therapeutics. Her current projects include data science/AI-powered prediction modeling of survival, treatment response, cancer recurrence, and metastasis in different cancer subtypes; detection of occult invasive breast cancer; and identification of novel therapeutic targets. Her goal is to translate her research findings back to the clinical setting for the benefit of patients with difficult-to-treat cancers.
-
Charlotte D. Jacobs M.D.
Drs. Ben and A. Jess Shenson Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsClinical Interests: general oncology, sarcomas. Research Interests: clinical trials in solid tumors.
-
Prasanna Jagannathan
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsWe study innate immunity and immune regulation of Plasmodium Falciparum malaria in children and pregnant women. Our work focuses on understanding how malaria shapes the immune state in individuals following repeated exposure. We are also testing novel interventions to enhance protective immunity against malaria in children via large, randomized controlled trials. Our work in malaria has been based in Eastern Uganda, where malaria transmission is among the highest in the world.
-
Sneha Shah Jain MD, MBA
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sneha S. Jain is a Clinical Assistant Professor of Medicine in the Division of Cardiovascular Medicine and Director of the GUIDE-AI Lab. She specializes in general cardiovascular medicine and preventive cardiology.
Dr. Jain pursued her undergraduate degree in Economics at Duke University and graduated with distinction. She received her medical degree from the Johns Hopkins School of Medicine and her MBA from Harvard Business School. She completed internal medicine residency training at Columbia/NewYork-Presbyterian, and fellowship training in cardiovascular medicine at Stanford University.
Her research focuses on the development and responsible evaluation of AI tools to augment healthcare delivery and improve patient outcomes. She works with the Data Science Team at Stanford Healthcare and the Stanford Center for Clinical Research to deploy and prospectively evaluate AI solutions across the healthcare enterprise. She serves on the American College of Cardiology Healthcare Innovation Section leadership council, the American Heart Association Expert Panel for the AI Validation Lab, and as an Expert AI consultant for the Journal of the American College of Cardiology.
